Concepedia

H. Yang

HY

Statistics

Publications

4

Citations

472

H-Index

4

Active since

2004

Affiliations

Duke Medical Center(Current)

Duke University

Clinical Research Institute

H. Yang is an author at Duke Medical Center specializing in pharmacology, clinical pharmacology, and ischemic heart disease.

Publications per year

2004–2021

4

Publications

4

Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: observations from the ARISTOTLE trial

Sigrun Halvorsen, Dan Atar, H. Yang et al. · European Heart Journal · 2014 · 368 citations · Full text

, , +17

First experience with direct, selective factor Xa inhibition in patients with non-ST-elevation acute coronary syndromes: results of the XaNADU-ACS Trial

John H. Alexander, H. Yang, Richard C. Becker et al. · Journal of Thrombosis and Haemostasis · 2005 · 48 citations · Full text

, , +15

Initial experience with factor‐Xa inhibition in percutaneous coronary intervention: the XaNADU‐PCI Pilot

John H. Alexander, Christopher K. Dyke, H. Yang et al. · Journal of Thrombosis and Haemostasis · 2004 · 45 citations · Full text

, , +15

Insight into the ecology of vaginal bacteria through integrative analyses of metagenomic and metatranscriptomic data

Michael France, Li Fu, Lindsay Rutt et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2021 · 11 citations · Full text

, , +15

1–4 of 4